| 1 |
35197754 | Linsitinib and aspirin as the IGF1-R antagonists, inhibit regorafenib-resistant chemotherapy in colon cancer. | 2022 Feb |
3 |
| 2 |
31181647 | Ramucirumab and GSK1838705A Enhance the Inhibitory Effects of Low Concentration Sorafenib and Regorafenib Combination on HCC Cell Growth and Motility. | 2019 Jun 7 |
2 |
| 3 |
29262576 | IGF-1R tyrosine kinase inhibitors and Vitamin K1 enhance the antitumor effects of Regorafenib in HCC cell lines. | 2017 Nov 28 |
1 |
| 4 |
24952730 | GIST treatment options after tyrosine kinase inhibitors. | 2014 Sep |
1 |